Research led by the University of Plymouth and Technische Universität Dresden has identified a new therapeutic target for cancer treatment and tissue regeneration - a protein called Prominin-1. Dr Bing Hu from Plymouth's Institute of Translational and Stratified Medicine (ITSMed) together with Dr Denis Corbeil from the Technische Universität Dresden and a multinational team has shown how Prominin-1 (also known as CD133) plays a significant role in ensuring stem cells respond to extracellular signals.
Continue reading...
No comments:
Post a Comment